Rice University statistician Genevera AllenCredit: Tommy LaVergne / Rice University
Rice University statistician Genevera Allen says scientists must keep questioning the accuracy and reproducibility of scientific discoveries made by machine learning techniques until researchers develop new computational systems that can critique themselves.
Allen, associate professor of statistics, computer science and electrical and computer engineering at Rice and of pediatrics-neurology at Baylor College of Medicine, will address the topic in both a press briefing and a general session today at the 2019 Annual Meeting of the American Association for the Advancement of Science (AAAS).
Get training in Lab Crisis Preparation and earn CEUs.
One of over 25 IACET-accredited courses in the Academy.
Lab Crisis Preparation course
"The question is, 'Can we really trust the discoveries that are currently being made using machine learning techniques applied to large data sets?'" Allen said. "The answer in many situations is probably, 'Not without checking,' but work is underway on next-generation machine-learning systems that will assess the uncertainty and reproducibility of their predictions."
Machine learning (ML) is a branch of statistics and computer science concerned with building computational systems that learn from data rather than following explicit instructions. Allen said much attention in the ML field has focused on developing predictive models that allow ML to make predictions about future data based on its understanding of data it has studied.
"A lot of these techniques are designed to always make a prediction," she said. "They never come back with 'I don't know,' or 'I didn't discover anything,' because they aren't made to."
She said uncorroborated data-driven discoveries from recently published ML studies of cancer data are a good example.
"In precision medicine, it's important to find groups of patients that have genomically similar profiles so you can develop drug therapies that are targeted to the specific genome for their disease," Allen said. "People have applied machine learning to genomic data from clinical cohorts to find groups, or clusters, of patients with similar genomic profiles.
"But there are cases where discoveries aren't reproducible; the clusters discovered in one study are completely different than the clusters found in another," she said. "Why? Because most machine-learning techniques today always say, 'I found a group.' Sometimes, it would be far more useful if they said, 'I think some of these are really grouped together, but I'm uncertain about these others.'"
